Skip to main content
Rural Health Information Hub

Barriers to MOUD in Rural Areas

While some rural communities have built extensive capacity to treat opioid use disorder (OUD) in response to the opioid crisis, some face barriers to accessing OUD treatment. Barriers include a lack of treatment facilities that offer medication for opioid use disorder (MOUD) or other treatment options, requiring patients to travel farther to access care. According to the Pew Charitable Trusts, almost 90% of rural communities lack the number of opioid treatment programs needed to meet demand.


Many rural patients with OUD will have to travel outside their community to access MOUD due to the limited treatment options available in most rural communities. Many rural residents seeking MOUD face transportation barriers, including lack of a driver's license, lack of access to a car, and lack of public transportation in the community. Additionally, transportation time and costs have been shown to be barriers to care. Patients may need to rely on friends or family to take them to appointments if they do not have a license or other means of transportation. These transportation barriers can jeopardize follow-up visits and adherence to treatment. To reduce this burden, providers can consider prescribing medication that can be administered unsupervised at home and can consider telehealth options to prescribe medication, communicate with patients, and counsel patients virtually.

Provider Knowledge, Attitudes, and Beliefs

In many rural communities, primary care providers serve large geographic areas and double as mental health and substance use disorder treatment providers to address a shortage of specialty care. A provider's willingness to deliver MOUD may be influenced by other perceived barriers, including:

  • Concerns about medication diversion or misuse
  • Time constraints
  • Lack of mental and behavioral health support services
  • Concerns about attraction of drug users to the practice
  • Concerns about DEA intrusion
  • Financial and reimbursement concerns
  • Resistance from practice partner(s)
  • Limited availability of specialty care providers
  • Lack of confidence in clinical skills to manage OUD
  • Perceived lack of need for MOUD services

Many providers express a lack of confidence in their knowledge of substance use disorders and their ability to treat patients with OUD. Very few medical schools require coursework or competencies treating substance use disorders. Even with a basic understanding of substance use treatment, providers may not have the expertise needed to treat more complex patients. To overcome this barrier, providers may refer patients to local opioid treatment programs, where available, or use telehealth to connect patients with specialists or other MOUD supports.


Stigma can be a significant barrier to seeking treatment for OUD. Patients may decide not to seek treatment out of fear of losing their job or jeopardizing relationships with friends and family. Providers and local organizations can be important advocates for reducing stigma by discussing substance use disorders as chronic brain diseases, sharing the evidence that supports using medication for treatment, and building awareness, knowledge, and support for MOUD programs in their local communities. Additional information and program considerations for addressing stigma is available in Module 4.


Technology can improve access and quality of MOUD programs, and it can also present unique challenges for rural communities. Both patients and providers may lack the technology infrastructure needed to use health information technology (HIT) systems or telehealth, such as limited internet access and availability of devices like laptops or cell phones. Adopting new technologies requires significant financial investment that can be a barrier for many rural patients and practices. For more information, see the Rural Telehealth Toolkit.

Resources to Learn More

Medications for Opioid Use Disorder Improve Patient Outcomes
Provides an overview of opioid use disorder (OUD) and discusses FDA-approved medications for treating OUD and their effectiveness. Emphasizes the importance of psychosocial treatment and discusses barriers to accessing treatment.
Organization(s): The Pew Charitable Trusts
Date: 12/2020